Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 22,011,900 | 22,972,800 | 22,485,900 | 21,445,800 | 21,199,000 |
| Cost of Goods | 5,149,600 | 4,965,700 | 4,436,900 | 4,004,900 | 3,624,800 |
| Gross Profit | 16,862,300 | 18,007,100 | 18,049,000 | 17,440,900 | 17,574,200 |
| Operating Expenses | 11,004,100 | 11,249,600 | 9,481,100 | 8,330,300 | 8,157,800 |
| Operating Income | 5,858,801 | 6,758,200 | 8,568,801 | 9,111,501 | 9,417,199 |
| Other Income | 1,505,099 | 1,244,600 | 482,799 | 540,199 | 530,901 |
| Pre-tax Income | 7,363,900 | 8,002,800 | 9,051,600 | 9,651,700 | 9,948,100 |
| Income Tax | 2,732,600 | 2,172,700 | 2,462,000 | 2,856,900 | 2,894,900 |
| Net Income Continuous | 4,631,300 | 5,830,100 | 6,589,600 | 6,794,800 | 7,053,200 |
| Net Income Discontinuous | N/A | N/A | 241,300 | 354,700 | 228,600 |
| Net Income | $4,631,300 | $5,830,100 | $6,830,900 | $7,149,500 | $7,281,800 |
| EPS Basic Total Ops | 2.11 | 2.63 | 3.05 | 3.17 | 3.18 |
| EPS Basic Continuous Ops | 2.11 | 2.63 | 2.95 | 3.01 | 3.08 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.11 | 0.16 | 0.10 |
| EPS Diluted Total Ops | 2.10 | 2.62 | 3.03 | 3.14 | 3.14 |
| EPS Diluted Continuous Ops | 2.10 | 2.62 | 2.92 | 2.98 | 3.04 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.11 | 0.16 | 0.10 |
| EBITDA(a) | $7,566,901 | $8,208,900 | $9,883,001 | $10,342,700 | $10,549,700 |